000 01484 a2200445 4500
005 20250514232447.0
264 0 _c20051207
008 200512s 0 0 eng d
022 _a0969-8051
024 7 _a10.1016/j.nucmedbio.2005.04.006
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMansard, Sandrine
245 0 0 _aUptake in melanoma cells of N-(2-diethylaminoethyl)-2-iodobenzamide (BZA2), an imaging agent for melanoma staging: relation to pigmentation.
_h[electronic resource]
260 _bNuclear medicine and biology
_cJul 2005
300 _a451-8 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aBenzamides
_xpharmacokinetics
650 0 4 _aCell Line, Tumor
650 0 4 _aHaloperidol
_xmetabolism
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMelanins
_xmetabolism
650 0 4 _aMelanoma
_xmetabolism
650 0 4 _aMice
650 0 4 _aMice, Inbred C57BL
650 0 4 _aNeoplasm Staging
650 0 4 _aPigmentation
650 0 4 _aTissue Distribution
700 1 _aPapon, Janine
700 1 _aMoreau, Marie-France
700 1 _aMiot-Noirault, Elisabeth
700 1 _aLabarre, Pierre
700 1 _aBayle, Martine
700 1 _aVeyre, Annie
700 1 _aMadelmont, Jean-Claude
700 1 _aMoins, Nicole
773 0 _tNuclear medicine and biology
_gvol. 32
_gno. 5
_gp. 451-8
856 4 0 _uhttps://doi.org/10.1016/j.nucmedbio.2005.04.006
_zAvailable from publisher's website
999 _c15640077
_d15640077